Buy Protodesnitazene (designer) Cas 805212-21-9
Protodesnitazene is a benzimidazole derivative which has been sold as a designer drug, and has potent opioid effects. It has been identified in Canada, Australia, the United Kingdom and Finland, first appearing in early 2025.[1][2][3][4][5][6][7][8]





Reviews
There are no reviews yet.